Kosan Biosciences Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/08 Q1

ended 12/31/07 FY 2007

ended 09/30/07 Q3

ended 06/30/07 Q2

ended 03/31/07 Q1

Prospectuses and Registrations Filter

Removal from listing

Securities registration termination

Tender offer solicitation – amended

Third party tender offer – amended

Tender offer solicitation – amended

Ownership Filter

Great Point Partners LLC

Federated Hermes Inc.

OppenheimerFunds, Inc.

Orbimed Advisors LLC

Wright Jonathan K.

News Filter

BRISTOL-MYERS SQUIBB TO ACQUIRE KOSAN BIOSCIENCES Bristol-Myers Squibb Advances Company Strategy With Latest Acquisition

Change in Directors, Officers or Compensation

Announces First Quarter 2008 Financial Results

Initiates Phase 2 Trial of Epothilone Kos-1584 in Non-Small Cell Lung Cancer

Cost of Exit or Disposal Activities, Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Confidential treatment order

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness